Physician profile
Paul N Backas
NPI 1063463511
$798.14
in general payments reported to CMS, 2019-2025
12 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $139 · 2022: $50.95 · 2023: $38.80 · 2024: $91.93 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $134.43 | 2019 | |
| Medtronic USA, INC. | $121.60 | 2019 | |
| Sirtex Medical INC | $93.74 | 2019-2020 | |
| Ge Healthcare | $92.82 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.93 | 2024 | |
| Angiodynamics, INC. | $74.79 | 2019-2022 | |
| Boston Scientific Corporation | $59.59 | 2025 | Embold Fibered |
| Argon Medical Devices, INC. | $51.40 | 2025 | Clot Management |
| Edwards Lifesciences Corporation | $24.51 | 2023 | Sapien 3 Ultra Resilia |
| Telix Pharmaceuticals | $22.46 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.58 | 2020 | |
| Teleflex LLC | $14.29 | 2023 | Guideliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Backas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.